MedPath

The PerX360º System™ Registry

Conditions
DDD
Registration Number
NCT01796535
Lead Sponsor
Interventional Spine, Inc.
Brief Summary

This is a multi-center, non-randomized post marketing surveillance registry including up to 125 patients treated with the PerX360º System™. Patients will receive a follow-up evaluation at the per physician defined time points: at discharge, an Interim 1 visit (1 month), an Interim 2 visit (3-6 months) and a Final visit (12 months). Imaging obtained at visits should be per standard of care.

Detailed Description

For all patients participating in the registry, the following outcomes will be analyzed:

* Change in pain score on the Visual Analog Scale(VAS) from baseline for leg pain

* Change in pain score on the Visual Analog Scale(VAS) from baseline for back pain

* Change in Oswestry Disability Index (ODI) score from baseline

* Proportion of patients with a device related complication

* Proportion of patients with lack of revision, removal, or reoperation

* Proportion of patients with radiographic fusion

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
125
Inclusion Criteria
  • Patient understands the nature of the procedure and provides written informed consent
  • Patient is willing to return to the treating physician for his/her routine follow-up visits up to 12 months post treatment
  • Age > 18 years
  • Patient is treated with the Optiport™ and Opticage™ products
Exclusion Criteria

None

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Fusion1 year

Image Assessment

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

Flagler Hospital

🇺🇸

St. Augustine, Florida, United States

Los Angeles Brain and Spine Institute

🇺🇸

Los Angeles, California, United States

© Copyright 2025. All Rights Reserved by MedPath